Mirjam Nägeli
Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
Ramelyte E, Nägeli M, Hunger R, Merat R, Gaide O, Navarini A, Cozzio A, Wagner N, Maul L, Dummer R. Swiss Recommendations for Cutaneous Basal Cell Carcinoma. Dermatology 2022; 239:1-10.
22.09.2022Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
22.09.2022Dermatology 2022; 239:1-10
Ramelyte Egle, Nägeli Mirjam, Hunger Robert, Merat Rastine, Gaide Olivier, Navarini Alexander A, Cozzio Antonio, Wagner Nikolaus, Maul Lara Valeska, Dummer Reinhard
Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study)
Stenz N, Hofbauer G, Nägeli M, Mühlstädt M, Laffitte E, Hunger R, Harms M, Gaide O, Dickenmann M, Cozzio A, Arnold A, Stampf S, and The Swiss Transplant Cohort Study. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study). Dermatology 2020:1-11.
23.11.2020Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study)
23.11.2020Dermatology 2020:1-11
Stenz Nadja Angela, Hofbauer Günther F L, Nägeli Mirjam, Mühlstädt Michael, Laffitte Emmanuel, Hunger Robert E, Harms Mirjam, Gaide Olivier, Dickenmann Michael, Cozzio Antonio, Arnold Andreas W, Stampf Susanne, and The Swiss Transplant Cohort Study
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Saulite I, Bobrowicz M, Hoetzenecker W, Pascolo S, Scarisbrick J, Dummer R, Cozzio A, Nägeli M, Anzengruber F, Varypataki E, Dimitriou F, Fassnacht C, Chang Y, Desislava I, Guenova E. Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation. Oncoimmunology 2020; 9:1738797.
18.03.2020Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
18.03.2020Oncoimmunology 2020; 9:1738797
Saulite Ieva, Bobrowicz Malgorzata, Hoetzenecker Wolfram, Pascolo Steve, Scarisbrick Julia, Dummer Reinhard, Cozzio Antonio, Nägeli Mirjam, Anzengruber Florian, Varypataki Eleni, Dimitriou Florentia, Fassnacht Christina, Chang Yun-Tsan, Desislava Ignatova, Guenova Emmanuella
Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease.
Nordmann T, Messerli-Odermatt O, Meier L, Micaletto S, Coppetti T, Nägeli M, Kamarachev J, Kudura K, Freiberger S, Rordorf T, Mangana J, Braun R, Dummer R. Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease. Oncotarget 2019; 10:6647-6650.
19.11.2019Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease.
19.11.2019Oncotarget 2019; 10:6647-6650
Nordmann Thierry M, Messerli-Odermatt Olivia, Meier Larissa, Micaletto Sara, Coppetti Thomas, Nägeli Mirjam, Kamarachev Jivko, Kudura Ken, Freiberger Sandra N, Rordorf Tamara, Mangana Joanna, Braun Ralph, Dummer Reinhard
The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis
Bentele-Jaberg N, Guenova E, Mehra T, Nägeli M, Chang Y, Cozzio A, French L, Hoetzenecker W. The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis. Dermatology (Basel) 2015; 231:99-102.
01.07.2015The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis
01.07.2015Dermatology (Basel) 2015; 231:99-102
Bentele-Jaberg Nicoletta, Guenova Emmanuella, Mehra Tarun, Nägeli Mirjam, Chang Yung-Tsan, Cozzio Antonio, French Lars E, Hoetzenecker Wolfram